<DOC>
	<DOCNO>NCT01434680</DOCNO>
	<brief_summary>The study evaluate safety immune response three lot Novartis Meningococcal C Conjugate Vaccine ( MenC-CRM Liquid ) administer Healthy Toddlers .</brief_summary>
	<brief_title>Evaluating Comparative Safety Immunogenicity Three Lots Novartis Meningococcal C Conjugate Vaccine Healthy Toddlers</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>1 . Healthy 12 23 ( inclusive ) monthold male female toddler . 2 . A parent/legal guardian give write informed consent nature study explain . 3 . Available visit schedule study . 4 . In good health determine medical history , physical examination clinical judgment investigator . 1 . History meningococcal vaccine administration . 2 . Previous know suspected disease cause N. meningitidis . 3 . Household contact and/or intimate exposure individual laboratory confirm N. meningitidis infection colonization . 4 . History severe allergic reaction previous vaccination , allergy Latex , hypersensitivity component vaccine . 5 . Significant acute chronic infection within previous 7 day axillary temperature ≥38.0°C within previous 3 day . 6 . Individuals receive antibiotic within 6 day vaccination . 7 . Known suspected autoimmune disease impairment/alteration immune system result ( example ) : Receipt immunosuppressive therapy time since birth . Receipt immunostimulants time since birth . Receipt systemic corticosteroid chronic use inhale highpotency corticosteroid since birth ( use topical corticosteroid administer limited area body [ example , eczema knee face elbow ] allow ) . Immune deficiency disorder , know HIV infection . 8 . History seizure , progressive neurological disease Guillain Barré Syndrome ( exception : one selflimited nonmedicated febrile seizure acceptable ) . 9 . Known bleed diathesis , condition may associate prolonged bleeding time . 10 . Receipt blood , blood product and/or plasma derivative parenteral immunoglobulin preparation past 12 week . 11 . Taken antipyretic medication previous 6 hour . 12 . Received vaccine within 30 day prior enrollment intent receive vaccine study ( Exception : Inactivated influenza vaccine may administer 15 day prior study immunization le 15 day study immunization ) . 13 . Toddler 's parent ( ) legal guardian ( ) able comprehend follow require study procedure whole period study . 14 . Participation clinical trial another investigational product 30 day prior first study visit intent participate another clinical study study . 15 . Family member household member site research staff . 16 . History illness/condition , opinion investigator , might interfere result study pose additional risk subject due participation study . 17 . Any serious chronic progressive disease accord judgment investigator ( neoplasm , insulin dependent diabetes , cardiac , renal hepatic disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Meningococcal disease</keyword>
	<keyword>vaccine</keyword>
	<keyword>toddler</keyword>
	<keyword>prevention</keyword>
	<keyword>Meningitis</keyword>
</DOC>